Computing Community Consortium Blog

The goal of the Computing Community Consortium (CCC) is to catalyze the computing research community to debate longer range, more audacious research challenges; to build consensus around research visions; to evolve the most promising visions toward clearly defined initiatives; and to work with the funding organizations to move challenges and visions toward funding initiatives. The purpose of this blog is to provide a more immediate, online mechanism for dissemination of visioning concepts and community discussion/debate about them.

NIH-led Effort Launches Big Data Portal for Alzheimer’s Drug Discovery

March 10th, 2015 / in big science, policy, research horizons, Research News / by Helen Wright


The National Institute of Health (NIH) is determined to reduce the cost and time it takes to discover viable therapeutic targets, which drive the changes in the molecular networks leading to the signs and symptoms of Alzheimer’s disease.

NIH is leading the U.S. Food and Drug Administration and various other industry and academic scientists in a public-private partnership effort to create a Big Data portal for Alzheimer’s drug discovery. This Accelerating Medicine Partnership for Alzheimer’s disease (AMP-AD) Knowledge Portal is public so it will enable sharing, transparency, reproducibility, and analysis of large biomedical datasets. The hope is that it will shorten the time between discovery of potential drug targets to development of new drugs for the treatment and prevention of Alzheimer’s disease.

The AMP-AD Knowledge Portal is available on Synapse, which is a public workspace that allows registered users to aggregate, describe, and share their research. AMP-AD data is available for users to incorporate into their own research programs and may be analyzed in combination with other data.

To learn more, see the NIH press release and visit the AMP-AD Big Data Portal.

NIH-led Effort Launches Big Data Portal for Alzheimer’s Drug Discovery

Comments are closed.